tiprankstipranks
TipRanksTop Financial ExpertsInsidersDavid Schenkein

David Schenkein Insider Profile

4 Followers
David Schenkein, Director at Prime Medicine, Inc., holds ― shares in Prime Medicine, Inc. (Ticker: PRME), holds 79.13K shares in Denali Therapeutics (Ticker: DNLI), holds 448.00 shares in Regeneron (Ticker: REGN). Most recently, David Schenkein ― shares of Prime Medicine, Inc. on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
David Schenkein

David Schenkein
Prime Medicine, Inc. (PRME)
Director

Ranked #43,889 out of 108,921 Corporate Insiders

Profitable Transactions

47%
7 out of 15 Profitable Transactions

Average Return

+0.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$18M
88.07%
9.85%
2.07%
0.00%
A breakdown of David Schenkein's holdings
See the Top Stocks by Insiders

Insider Roles

Agios Pharma
(AGIO)
Director
Denali Therapeutics
(DNLI)
Director
Regeneron
(REGN)
Director
Prime Medicine, Inc.
(PRME)
Director
Roles that David Schenkein holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Agios Pharma
(AGIO)
Rating:Informative Buy
Date:Mar 27, 2014 - Mar 27, 2015
Return:+164.20%
The most profitable trade made by David Schenkein
See the Latest Stocks Traded by Insiders

David Schenkein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PRME
Prime Medicine, Inc.
―
Director
―
―
REGN
Regeneron
Jan 06, 2025
Director
Uninformative Buy
―
$370.82K
AGIO
Agios Pharma
Jun 17, 2024
Director
Uninformative Buy
158.46K
$15.76M
DNLI
Denali Therapeutics
Jun 05, 2026
Director
Uninformative Buy
―
$1.76M
FMI
Foundation Medicine
Jun 20, 2016
―
Uninformative Buy
240.65K
$2.98M
BLUE
Bluebird Bio
Jun 22, 2020
―
Uninformative Buy
―
$33.96K
List of latest transactions for each holding click on a transaction to see David Schenkein's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

David Schenkein insider profile FAQ

What is the percentage of profitable transactions made by David Schenkein?
The percentage of profitable transactions made by David Schenkein is 47%.
    What is the average return per transaction made by David Schenkein?
    The average return per transaction made by David Schenkein is 0.80%.
      What stocks does David Schenkein hold?
      David Schenkein holds: PRME, REGN, AGIO, DNLI, FMI, BLUE stocks.
        What was David Schenkein’s latest transaction?
        David Schenkein latest transaction was an Uninformative Buy of ―.
          What was David Schenkein's most profitable transaction?
          David Schenkein’s most profitable transaction was an Informative Buy of AGIO stock on March 27, 2014. The return on the trade was 164.20%.
            What is David Schenkein's role in Prime Medicine, Inc.?
            David Schenkein's role in Prime Medicine, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.